Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Low vitamin D and glutathione levels also correlate with increased Mtb growth in monocytes and poor Mtb control in MDMs, respectively (108, 112).

Source: Phagocytosis and mycobacterial killing in TB-DM. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

We conducted a systematic review of studies published between 1974 and May 31, 2023 that examined immunological mechanisms through which DM alters TB pathogenesis.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Immune dysregulation in tuberculosis-diabetes comorbidity: mechanistic and translational insights

Systematic review · Frontiers in Immunology · 2026

Original publication title

Immune dysregulation in tuberculosis-diabetes comorbidity: mechanistic and translational insights

Aminat Y. Saula; Muge Cevik; Jacqueline M. Cliff; Katharina Ronacher; Ruth Bowness

Copyright © 2026 Saula, Cevik, Cliff, Ronacher and Bowness.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our findings highlight DM as a key immunometabolic modifier of TB pathogenesis. They also suggest that earlier metabolic optimisation and host-directed therapeutic strategies could be explored as potential approaches to improve outcomes in this growing high-risk TB-DM population.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Tuberculosis (TB) remains a leading cause of infectious disease mortality worldwide, and the rising prevalence of diabetes mellitus (DM) represents a major obstacle to TB control. DM increases susceptibility to TB, worsens disease severity, delays treatment response, and is associated with poorer outcomes, largely through disruption of host immunity.

Source: Background

Abstract: What methods does the paper describe?

We conducted a systematic review of studies published between 1974 and May 31, 2023 that examined immunological mechanisms through which DM alters TB pathogenesis. In total, 81 eligible studies involving animal models, human participants, or combined approaches were identified and synthesised across different stages of TB.

Source: Methods

Abstract: Systematic review registration

Abstract: Results

Across studies, DM was associated with broad dysregulation of innate and adaptive immune responses, altered cytokine signalling, impaired granuloma structure and function, and reduced control of Mycobacterium tuberculosis (Mtb). Distinct immune profiles emerged between TB disease with DM and latent TB infection with DM, with heterogeneity partly explained by differences in study design, metabolic status, and disease stage. Importantly, emerging evidence indicates that pre-diabetes and intermediate hyperglycaemia may also compromise TB immunity and contribute to disease progression.

Source: Results

Abstract: Conclusion

Our findings highlight DM as a key immunometabolic modifier of TB pathogenesis. They also suggest that earlier metabolic optimisation and host-directed therapeutic strategies could be explored as potential approaches to improve outcomes in this growing high-risk TB-DM population.

Source: Conclusion
Authors’ abstract

Background

Tuberculosis (TB) remains a leading cause of infectious disease mortality worldwide, and the rising prevalence of diabetes mellitus (DM) represents a major obstacle to TB control. DM increases susceptibility to TB, worsens disease severity, delays treatment response, and is associated with poorer outcomes, largely through disruption of host immunity.

Methods

We conducted a systematic review of studies published between 1974 and May 31, 2023 that examined immunological mechanisms through which DM alters TB pathogenesis. In total, 81 eligible studies involving animal models, human participants, or combined approaches were identified and synthesised across different stages of TB.

Results

Across studies, DM was associated with broad dysregulation of innate and adaptive immune responses, altered cytokine signalling, impaired granuloma structure and function, and reduced control of Mycobacterium tuberculosis (Mtb). Distinct immune profiles emerged between TB disease with DM and latent TB infection with DM, with heterogeneity partly explained by differences in study design, metabolic status, and disease stage. Importantly, emerging evidence indicates that pre-diabetes and intermediate hyperglycaemia may also compromise TB immunity and contribute to disease progression.

Conclusion

Our findings highlight DM as a key immunometabolic modifier of TB pathogenesis. They also suggest that earlier metabolic optimisation and host-directed therapeutic strategies could be explored as potential approaches to improve outcomes in this growing high-risk TB-DM population.

Systematic review registration

https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42023431040.

Publication and source details

Original title: Immune dysregulation in tuberculosis-diabetes comorbidity: mechanistic and translational insights

Aminat Y. Saula; Muge Cevik; Jacqueline M. Cliff; Katharina Ronacher; Ruth Bowness

Frontiers in Immunology · 2026

* Correspondence: Aminat Y. Saula, ays27@bath.ac.uk

†These authors have contributed equally to this work

Copyright © 2026 Saula, Cevik, Cliff, Ronacher and Bowness.2026Saula, Cevik, Cliff, Ronacher and Bownesshttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. AYS is supported by a scholarship from the EPSRC Centre for Doctoral Training in Statistical Applied Mathematics at Bath (SAMBa), under project EP/S022945/1. MC was supported by the Chief Scientist Office (CAF/20/03), the British Infection Association (Grant/2022/SPG/MC), and Wellcome Trust ISSF (XISF8C/MC). KR received funding from the Mater Foundation and the Australian NHMRC (Grant No. 2019167). RB was supported by funding from the Medical Research Council (Grant number MR/Y010124/1).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:21:33.740408+00:00

DOI: 10.3389/fimmu.2026.1803046 · PMC13149154